SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Starsource Multitrade Ltd (506365)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506365 NSE: Pharmaceuticals & Drugs | Small Cap | Starsource Multitrad Share Price

₹117 2.00 (1.74%)

As on 04-Jun'26 16:59

Starsource Multitrade Ltd (506365)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506365 NSE: Pharmaceuticals & Drugs | Small Cap | Starsource Multitrad Share Price

₹117 2.00 (1.74%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹18 Cr.
Current Price
₹117
52-Week Low / High
₹75 / 153
TTM EPS
₹-79
TTM Sales
₹0.5 Cr.
Book Value per Share
₹8.5
P/E Ratio
0.00
Lower than its 5-year historical median
Industry PE
46.5
Price to Book (P/B)
13.71
Higher than its 5-year historical median
Price to Sales (P/S)
33.37
EV/EBITDA
-1.48
Lower than its 3-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
2.64%
Underperforms industry median
Return on Capital Employed (ROCE)
3.84%
Underperforms industry median
Return on Assets (ROA)
2.60%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-71.67%
Asset Quality
Promoter Holding
27.89%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹1.5 Cr.
Face Value
₹10
All Time Low / High
₹1.60 / 195.00

Starsource Multitrade stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Starsource Multitrade Ltd a good quality company?
Starsource Multitrade Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Starsource Multitrade Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Starsource Multitrade Ltd vs industry peers?
Starsource Multitrade Ltd revenue CAGR is %, compared to the industry median CAGR of 7.53%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Starsource Multitrade Ltd?
Promoters hold 27.89% of the Starsource Multitrade Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Starsource Multitrade Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 24.1% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Starsource Multitrade Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 6%68.4%7.5%2.5%4.7%2.9%3.2%0.8%13.5%3.8%-
Value Creation
Index
-0.63.9-0.5-0.8-0.7-0.8-0.8-1.00.0-0.7-

Growth Parameters

Sales 00000000001
Sales YoY Gr.-NANANANANANANANANA-
Adj EPS 1.57.60.71.42.81.73.22.37.93.1-79
YoY Gr.-424.1%-91.2%106%105.1%-41%90.4%-29.3%251.6%-60.8%-
BVPS (₹) 35.666.867.568.971.673.37777.485.487.68.5
Adj Net
Profit
0.21.10.10.20.40.30.50.31.20.5-12
Cash Flow from Ops. -0.46.4-1.7-5.54.8-0.4-0.3-0.70.7-0.3-
Debt/CF from Ops. -0.3000000000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS 8.8%1.8%-0.9%-60.8%
BVPS10.5%4.1%4.4%2.7%
Share Price 21.4% 33.3% 55.1% -10.7%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
4.214.81242.34.22.99.73.6-164.4
Op. Profit
Mgn %
000000000018.6
Net Profit
Mgn %
0000000000-2236.7
Debt to
Equity
00000000000
Working Cap
Days
000000000029
Cash Conv.
Cycle
00000000002

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0000000000
Operating Expenses + 0.170.270.340.560.480.330.500.610.180.29
Manufacturing Costs0000.020.0200000
Material Costs0000000000
Employee Cost 0.030.060.130.210.160.090.140.070.020.02
Other Costs 0.140.220.210.330.300.240.360.540.170.27
Operating Profit -0.17-0.27-0.34-0.56-0.48-0.33-0.50-0.61-0.18-0.29
Operating Profit Margin (%) ----------
Other Income + 0.495.611.110.8210.670.880.711.840.80
Exceptional Items 0000000000
Interest 00000000.0100
Depreciation 00000.020.020.020.010.010.01
Profit Before Tax 0.325.340.760.250.490.310.360.071.640.50
Tax 0.100.650.660.050.080.06-0.200.030.440.16
Profit After Tax 0.224.680.100.210.420.250.560.051.200.34
PAT Margin (%) ----------
Adjusted EPS (₹)1.531.20.71.42.81.73.70.38.02.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Starsource Multitrad - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 5.3410.0210.1210.3310.7410.9911.5511.6012.8013.14
Share Capital 1.501.501.501.501.501.501.501.501.501.50
Reserves 3.848.528.628.839.249.4910.0510.1011.3011.64
Debt +0.120.1200000000
Long Term Debt0.120.1200000000
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables0000000000
Others Liabilities 0.080.580.130.130.220.06-0.15-0.220.210.20
Total Liabilities 5.5310.7210.2610.4610.9711.0511.4011.3813.0213.34

Fixed Assets

Net Fixed Assets +00.01000.070.050.040.030.020.01
Gross Block0.090.090.010.010.110.110.110.110.110.11
Accumulated Depreciation0.080.0800.010.030.060.070.090.100.10
CWIP 0000000000
Investments 1.680.020.020.040.020.042.943.034.400.01
Inventories0000000000
Trade Receivables0000000000
Cash Equivalents flag 0.446.877.662.978.8110.876.196.066.1110.62
Others Assets 3.413.822.577.452.060.092.242.272.492.70
Total Assets 5.5310.7210.2610.4610.9711.0511.4011.3813.0213.34

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -0.436.41-1.66-5.484.83-0.41-0.33-0.680.72-0.28
PBT 0.325.340.760.250.490.310.360.071.640.50
Adjustment -0.49-0.52-1.08-0.80-0.97-0.51-0.65-0.70-0.84-0.56
Changes in Working Capital -0.182.25-0.68-4.895.39-0.130.02-0.050.09-0.02
Tax Paid -0.08-0.65-0.66-0.05-0.08-0.09-0.06-0.01-0.17-0.20
Cash Flow From Investing Activity + 0.490.521.080.791.01-0.190.970.63-0.5210.46
Capex 0000000000
Net Investments 000-0.020.01-0.720.30-0.08-1.379.89
Others 0.490.521.080.8010.530.670.710.850.57
Cash Flow From Financing Activity + 0-0.501.37001.96-2.12-0.08-0.15-0.16
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0-0.501.37001.96-2.12-0.08-0.15-0.16
Net Cash Flow 0.066.430.79-4.705.841.36-1.49-0.130.0510.02

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)4.1560.9912.023.942.34.970.419.842.64
ROCE (%)5.9668.417.542.54.692.863.240.7613.493.84
Asset Turnover Ratio0000000000
PAT to CFO Conversion(x)-1.951.37-16.6-26.111.5-1.64-0.59-13.60.6-0.82
Working Capital Days
Receivable Days0000000000
Inventory Days0000000000
Payable Days0000000000

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Starsource Multitrade Ltd FAQs

The current trading price of Starsource Multitrad on 04-Jun-2026 16:59 is ₹117.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Starsource Multitrad stood at ₹17.55 Cr

The latest P/E ratio of Starsource Multitrad as of 03-Jun-2026 is 0.00.

The latest P/B ratio of Starsource Multitrad as of 03-Jun-2026 is 13.71.

The 52-week high of Starsource Multitrad is ₹152.9 and the 52-week low is ₹75.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Starsource Multitrad is ₹0.53 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Starsource Multitrade Ltd is a below average quality company.

The key valuation ratios of Starsource Multitrade Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Starsource Multitrade Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Starsource Multitrade Ltd

Chemo Pharma Laboratories has been an established company since 1942 and has been making pharmaceuticals and also had diversified into bulk drugs. However, due to increase in competition and flow of new drugs, the company had to dispose the business and pay all its liabilities and dues.

Presently the company has its own cash resource, with this the company is proposing to diversify and to take over sick company which has excellent future potential. The company is in advance negotiation to some other company and soon rehab to acquire business in power and chemicals.

The board of directors of the company has been exploring new business opportunities since manufacturing operations becoming unviable were discontinued. The company has no secured loans and has surplus funds which can be leveraged to commence any new business.

The registered office of the company is located at 5, Kumud Apartment CHS, Karnik Road, Chikan Ghar, Kalyan, Thane District, Pin Code - 421301, Maharashtra.

 

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×